The role of N6-methyladenosine in the virus–host interaction and viral infection progression as shown earlier [70] allows for suggesting that METTL3-mediated activation of M6A may be considered a promising target for antiviral therapy. This evidence concerns the gene METTL3 and viral infectious disease.